Clinical Trial Detail

NCT ID NCT02288507
Title Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Hawaii
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.